Karyopharm Therapeutics Inc.KPTINASDAQ
Loading
Cash generated from core business operations
Latest
$-75.37M
↑ 38% vs avg
Percentile
P64
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
$-122.05M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-75.37M | +40.9% |
| 2024 | $-127.49M | -37.5% |
| 2023 | $-92.72M | +38.0% |
| 2022 | $-149.55M | -39.6% |
| 2021 | $-107.12M | +33.2% |
| 2020 | $-160.23M | +16.0% |
| 2019 | $-190.82M | -19.9% |
| 2018 | $-159.12M | -115.8% |
| 2017 | $-73.72M | +12.6% |
| 2016 | $-84.39M | - |